Inventor · disambiguated record
Francis Blanche
Also filed as: BLANCHE FRANCIS · BLANCHE FRANCIS P
39 granted patents·17 pending applications·470 citations·filing 1993–2019
98Inventor score
Top patents by PatentIndex Score
56 records- 0195US9617345B2Anti-CEACAM5 antibodies and uses thereofSANOFI SA·Filed 2015·Granted Apr 11, 2017·53 cites·20 claims
- 0295US8614299B2Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptideBAURIN NICOLAS·Filed 2010·Granted Dec 24, 2013·56 cites·27 claims
- 0391US11332542B2Anti-CEACAM5 antibodies and uses thereofSANOFI SA·Filed 2019·Granted May 17, 2022·4 cites·11 claims
- 0490US6485958B2Method for producing recombinant adenovirusGENCELL SA·Filed 1997·Granted Nov 26, 2002·103 cites·19 claims
- 0588US6537793B2Method of separating viral particlesAVENTIS PHARMA SA·Filed 2001·Granted Mar 25, 2003·44 cites·14 claims
- 0687US10457739B2Anti-CEACAM5 antibodies and uses thereofSANOFI SA·Filed 2017·Granted Oct 29, 2019·6 cites·40 claims
- 0787US9493529B2Robo1-Fc fusion protein and use thereof for treating tumoursBLANCHE FRANCIS·Filed 2011·Granted Nov 15, 2016·20 cites·11 claims
- 0887US8119770B2Modified soluble FGF receptor Fc fusions with improved biological activityBLANCHE FRANCIS·Filed 2007·Granted Feb 21, 2012·19 cites·20 claims
- 0986US7038026B2Purification of a triple heli formation with an immobilized oligonucleotideCENTELION·Filed 2001·Granted May 2, 2006·10 cites·33 claims
- 1085US6905862B2Method for producing recombinant adenovirusCENTELION·Filed 2002·Granted Jun 14, 2005·13 cites·11 claims
- 1183US8852593B2Antagonist antibodies and their fab fragments against GPVI and uses thereofBAURIN NICOLAS·Filed 2010·Granted Oct 7, 2014·8 cites·8 claims
- 1280US10112991B2Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptideSANOFI SA·Filed 2016·Granted Oct 30, 2018·2 cites·30 claims
- 1379US6825012B2DNA molecules, preparation and use in gene therapyGENCELL SA·Filed 2001·Granted Nov 30, 2004·5 cites·30 claims
- 1478US8017744B2Purification of a triple helix formation with an immobilized oligonucleotideCENTELION·Filed 2009·Granted Sep 13, 2011·1 cites·6 claims
- 1576US9382312B2Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptideSANOFI SA·Filed 2013·Granted Jul 5, 2016·2 cites·26 claims
- 1673US6207150B1Variants of thymidine kinase, nucleic acids encoding them, and methods of using themAVENTIS PHARMA SA·Filed 1997·Granted Mar 27, 2001·32 cites·37 claims
- 1770US6734008B2Composition intended for the preservation of infectious recombinant adenovirusesGENCELL SA·Filed 2001·Granted May 11, 2004·3 cites·15 claims
- 1866US6352839B1Streptogramins for preparing same by mutasynthesisAVENTIS PHARMA SA·Filed 1995·Granted Mar 5, 2002·9 cites·20 claims
- 1964US6833382B2Streptogramins and method for preparing same by mutasynthesisAVENTIS PHARMA SA·Filed 2001·Granted Dec 21, 2004·3 cites·27 claims
- 2064US6670157B1Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their useAVENTIS PHARMA SA·Filed 2000·Granted Dec 30, 2003·2 cites·20 claims
- 2164US6319672B1Purification of a triple helix formation with an immobilized oligonucleotideAVENTIS PHARMA SA·Filed 2000·Granted Nov 20, 2001·16 cites·21 claims
- 2262US9809653B2Anti-LAMP1 antibodies and antibody drug conjugates, and uses thereofSANOFI SA·Filed 2015·Granted Nov 7, 2017·1 cites·17 claims
- 2360US8399636B2Purification of a triple helix formation with an immobilized obligonucleotideCROUZET JOEL·Filed 2011·Granted Mar 19, 2013·0 cites·16 claims
- 2460US5891695APolypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their useRHONE POULENC RORER SA·Filed 1993·Granted Apr 6, 1999·9 cites·11 claims
- 2560US2019119365A1Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptideSANOFI SA·Filed 2018·Application pending·0 cites
- 2658US7514218B2Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interactionCENTELION·Filed 2006·Granted Apr 7, 2009·0 cites·17 claims
- 2758US7202078B2Composition intended for the preservation of infectious recombinant adenovirusesCENTELION·Filed 2004·Granted Apr 10, 2007·0 cites·10 claims
- 2858US7052838B2Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interactionCENTELION·Filed 2002·Granted May 30, 2006·0 cites·30 claims
- 2958US2004077005A1Novel topoisomerase IV, corresponding nucleotide sequences and uses thereofAVENTIS PHARMA SA·Filed 2003·Application pending·0 cites
- 3057US9441040B2Antagonist antibodies and their fab fragments against GPVI and uses thereofSANOFI SA·Filed 2014·Granted Sep 13, 2016·0 cites·15 claims
- 3157US2006019352A1Methods of increasing the production of cobalamins using cob gene expressionAVENTIS PHARMA SA·Filed 2003·Application pending·0 cites
- 3253US2005287657A1Method for producing recombinant adenovirusCENTELION·Filed 2005·Application pending·0 cites
- 3352US8481487B2Modified soluble FGF receptor Fc fusions methodBLANCHE FRANCIS·Filed 2012·Granted Jul 9, 2013·0 cites·26 claims
- 3451US2014030265A1Modified soluble fgf receptor fc fusions methodBLANCHE FRANCIS·Filed 2013·Application pending·0 cites
- 3551US2004052777A1Kringle polypeptides and methods for using them to inhibit angiogenesisFiled 2003·Application pending·0 cites
- 3651US2004052810A1Abrogen polypeptides, nucleic acids encoding them and methods for using them to inhibit angiogenesisFiled 2003·Application pending·0 cites
- 3750US6153597APharmaceutical composition useful for nucleic acid transfection, and use thereofAVENTIS PHARMA SA·Filed 1996·Granted Nov 28, 2000·13 cites·27 claims
- 3850US5591614AProcess for the enzymatic preparation of macrolactoneRHONE POULENC RORER SA·Filed 1995·Granted Jan 7, 1997·6 cites·8 claims
- 3950US2011150903A1Fgf-r4 receptor-specific antagonistsSANOFI AVENTIS·Filed 2009·Application pending·0 cites
- 4049US7090999B2Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their useSANOFI AVENTIS·Filed 2003·Granted Aug 15, 2006·0 cites·8 claims
- 4149US6518062B1Enzyme combinations for destroying proliferative cellsAVENTIS PHARMA SA·Filed 1997·Granted Feb 11, 2003·9 cites·25 claims
- 4248US2002102247A1Variants of thymidine kinase, related nucleic acids sequences and their use in genic therapyFiled 2000·Application pending·0 cites
- 4347US6001631ATopoisomerase IV, corresponding nucleotide sequences and uses thereofRHONE POULENC RORER SA·Filed 1995·Granted Dec 14, 1999·7 cites·17 claims
- 4446US2003170710A1Method of separating viral particlesAVENTIS PHARMA SA·Filed 2003·Application pending·0 cites
- 4545US2005099312A1Smoke detector with battery packFiled 2003·Application pending·0 cites
- 4644US2007111221A1Method of preparation for pharmaceutical grade plasmid DNABLANCHE FRANCIS·Filed 2006·Application pending·0 cites
- 4741US6656709B1Methods of increasing the production of cobalamins using cob gene expressionRHONE POULENC BIOCHIMIE·Filed 1995·Granted Dec 2, 2003·4 cites·58 claims
- 4841US2007213289A1Method for purifying plasmid DNACENTELION·Filed 2006·Application pending·0 cites
- 4941US2013108641A1Anti-gitr antibodiesBAURIN NICOLAS·Filed 2012·Application pending·0 cites
- 5040US6171846B1Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their useAVENTIS PHARMA SA·Filed 1999·Granted Jan 9, 2001·3 cites·20 claims
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Francis Blanche files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →